by David Heiger, Ph.D., Associate Vice President, Lab Enterprise Division, Agilent CrossLab Group, Agilent Technologies
2021 has brought hope and promise as many countries across the globe distribute vaccinations against the SARS-CoV-2 virus. But, rewind to a year ago, and many businesses and government-funded institutions had either shut down or reprioritized their operations to prevent the transmission of the virus. The scientific community was one of many sectors affected, with many laboratories temporarily shutting down, reducing their throughput, and others pivoting to meet the demands of the fight against COVID-19. Analytical instrument vendors were committed to supporting their customers with innovations that simplified, optimized, and transformed lab operations so that these businesses could adjust to the new normal and advance their lab performance.
Read more on Labcompare.